Cookie Consent by PrivacyPolicies.com

Publicaciones científicas

142 Publicaciones científicas disponibles

  • Safety and effectiveness of a prothrombin complex concentrate in approved and off-label indications

    25 de julio de 2019 | Revista: Transfusion Medicine

    Marcos-Jubilar M (1), García Erce JA (2), Martínez-Calle N (3), Páramo JA (1), Martínez Virto A (4), Quintana-Díaz M (5)

    (1) Hematology Service, Clínica Universidad de Navarra, Pamplona, Spain.
    (2) Banco de Sangre y Tejidos de Navarra, Pamplona, Spain.
    (3) Department of Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
    (4) Emergency Department, Hospital Universitario La Paz, Madrid, Spain.
    (5) Intensive Medicine, Hospital Universitario La Paz, Madrid, Spain.


  • Differences in Venous Thromboembolism Prevention and Outcome between Hospitalized Patients with Solid and Hematologic Malignancies

    30 de mayo de 2019 | Revista: TH Open

    Figueroa R (1), Alfonso A (1), Marcos M (1), López-Picazo JM (2), García-Mouriz A (3), Gil-Bazo I (2), Rifón J (1), Hermida J (4,5), Páramo JA (1,5), Lecumberri R (1,5).

    (1) Hematology Service, Clínica Universidad de Navarra, Pamplona, Navarra, Spain.
    (2) Department of Oncology, Clínica Universidad de Navarra, Pamplona, Navarra, Spain.
    (3) Informatics Service, Clínica Universidad de Navarra, Pamplona, Navarra, Spain.
    (4) Center for Applied Medical Research, University of Navarra, Pamplona, Navarra, Spain.
    (5) CIBER-CV, Pamplona, Navarra, Spain.


  • Aumento selectivo de vesículas extracelulares derivadas de cardiomiocitos después de un infarto de miocardio experimental y efectos funcionales en el endotelio

    1 de agosto de 2018 | Revista: Thrombosis Research

    Rodriguez JA (1), Orbe J (1), Saenz-Pipaon G (2), Abizanda G (3), Gebara N (2), Radulescu F (2), Azcarate PM (4), Alonso-Perez L (4), Merino D (5), Prosper F (6), Paramo JA (7), Roncal C (8).

    (1) Laboratory of Atherothrombosis, Program of Cardiovascular Diseases, Center for Applied Medical Research (CIMA)-University of Navarra, Spain; CIBERCV, Madrid, Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Spain.
    (2) Laboratory of Atherothrombosis, Program of Cardiovascular Diseases, Center for Applied Medical Research (CIMA)-University of Navarra, Spain.
    (3) IdiSNA, Instituto de Investigación Sanitaria de Navarra, Spain; Hematology Service, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.
    (4) Departamento de Cardiología, Hospital San Pedro, Logroño, Spain.
    (5) Flow Cytometry and Cell Sorting Core, Health Research Institute-IDIVAL, Santander, Spain.
    (6) IdiSNA, Instituto de Investigación Sanitaria de Navarra, Spain; Hematology Service, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain; CIBERONC, Madrid, Spain.
    (7) Laboratory of Atherothrombosis, Program of Cardiovascular Diseases, Center for Applied Medical Research (CIMA)-University of Navarra, Spain; CIBERCV, Madrid, Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Spain; Hematology Service, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.
    (8) Laboratory of Atherothrombosis, Program of Cardiovascular Diseases, Center for Applied Medical Research (CIMA)-University of Navarra, Spain; CIBERCV, Madrid, Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Spain


  • CM352 Reduces Brain Damage and Improves Functional Recovery in a Rat Model of Intracerebral Hemorrhage

    1 de junio de 2017 | Revista: Journal of American Heart Association

    Rodríguez JA (1,2), Sobrino T (3), López-Arias E (4), Ugarte A (5), Sánchez-Arias JA (5), Vieites-Prado A (4), de Miguel I (5), Oyarzabal J (5), Páramo JA (6,2), Campos F (4), Orbe J (7), Castillo J (4,2).

    (1) Atherosclerosis Research Laboratory, Health Research Institute of Navarra-IdiSNA, University of Navarra, Pamplona, Spain.
    (2) CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain.
    (3) Clinical Neurosciences Research Laboratory, Department of Neurology, Hospital Clínico Universitario, Health Research Institute of Santiago de Compostela, Universidade de Santiago de Compostela, Spain
    (4) Clinical Neurosciences Research Laboratory, Department of Neurology, Hospital Clínico Universitario, Health Research Institute of Santiago de Compostela, Universidade de Santiago de Compostela, Spain.
    (5) Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research, Health Research Institute of Navarra-IdiSNA, University of Navarra, Pamplona, Spain.
    (6) Hematology Service, Clínica Universidad de Navarra, Health Research Institute of Navarra-IdiSNA, University of Navarra, Pamplona, Spain.
    (7) Atherosclerosis Research Laboratory, Health Research Institute of Navarra-IdiSNA, University of Navarra, Pamplona, Spain

No hay más publicaciones científicas

No hay más páginas para cargar